CDD’s 10th Anniversary Community Meeting Agenda

Friday, April 4, 2014

Mission Bay Conference Center
Robertson Auditorium
1675 Owens St.
San Francisco, CA 94143

  • 7:45 - Registration
    Refreshments in Foyer and Exhibition room
  • 8:15 - Opening Remarks
    With UCSF Host, Stephanie Robertson and CDD CEO, Barry Bunin
  • 8:20 - Collaborative Workflow: Basic and Advanced Use Cases of CDD Vault
    Charlie Weatherall (CDD) & Anna Spektor (CDD)
  • 9:10 - Morning Sessions
    Moderated by Sylvia Ernst (CDD)
  • 9:15 - The Rockefeller University Compound Screening Library
    J. Fraser Glickman (Rockefeller University)
  • 9:40 - Recent Progress in De-Orphanization of Nuclear Receptors
    Ruo Steensma (Orphagen Pharmaceuticals)
  • 10:05 - Morning Break
    Located in the Foyer and Exhibition room
  • 10:35 - Large small molecules in a Small large molecule world
    Leanna Staben (Genentech)
  • 11:00 - Linking the Molecular Structure of Medicines to their Biological Effects
    Bob Volkmann (Systamedic & Mnemosyne Pharmaceuticals)
  • 11:25 - Panel: Externalized Research - What Makes a Good Partnership? Wisdom from Experts
    Who've "Been There - Done That," moderated by Sylvia Ernst (CDD)
  • 11:50 - Lunch
    boxed lunches in the Foyer and Exhibition room
  • (12:35) - Optional: “What if CDD had...” provide feedback to our product team
    Kellan Gregory (CDD)
  • 1:05 - 10 Years Evolving Our Collaborative Drug Discovery Vaults
    Barry Bunin (CDD)
  • 1:30 - CDD Vault: Noteworthy recent enhancements and a preview of things to come
    David Blondeau (CDD) & Kellan Gregory (CDD)
  • 2:20 - Afternoon sessions: moderated by Christopher Lipinski
  • 2:25 - The Tuberculosis Drug Accelerator: A New Paradigm For Drug Discovery
    Jerry Shipps (Tuberculosis Drug Accelerator)
  • 2:50 - The role of NIAID in the development of therapeutics for Infectious Diseases
    Martin John Rogers (NIAID)
  • 3:15 - Afternoon Break
    Located in the Foyer and Exhibition Room
  • 3:40 - Targeting the Immunoproteasome
    Dustin L. McMinn (Onyx Pharmaceuticals)
  • 4:10 - Hit Generation for the Treatment of Prion Diseases Using Phenotypic Screens
    Joel Gever (UCSF)
  • 4:35 - Exploiting Bigger Data and Collaborative Tools for Predictive Drug Discovery
    Sean Ekins (CDD)
  • 5:00 - Lipinski CDD 10th Anniversary Thoughts on Drug Discovery
    Christopher Lipinski
  • 5:30 - Panel: Perspectives on Drug Discovery Collaborations
    Moderated by Christopher Lipinski
  • 5:55 - Wine and Cheese Reception
    Located in the Foyer